Copyright
©2012 Baishideng.
World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 7-20
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7
Table 1 Non-genetic risk factors for gallbladder stones
| Age |
| Female gender |
| High-calorie, low-fiber diet |
| High-carbohydrate diet, dietary glycemic load |
| Obesity |
| Physical inactivity |
| Rapid weight loss/surgery for obesity |
| Total gastrectomy with lymph node dissection |
| Spinal cord injury |
| Infections: enterohepatic Helicobacter species, malaria |
| Biliary strictures |
| Drugs: estrogens, calcineurin inhibitors, fibrates, octreotide, ceftriaxone |
| Total parenteral nutrition |
| Duodenal diverticulum |
| Extended ileal resection (black pigment stones) |
| Vitamin B12/folic acid deficient diet (black pigment stones) |
| Pancreatic insufficiency |
| Cholangitis (brown pigment bile duct stones) |
Table 2 Major features of the uncomplicated biliary colic
| Pathogenesis | Visceral pain caused by the impaction of the stone in the cystic duct or the ampulla of Vater, followed by distension of the gallbladder and/or biliary tract with activation of visceral sensory neurons[161] |
| Onset | Not exclusively postprandial, typically intermittent |
| Intensity | Mean visual analogue scale of 9 cm on a 0-10 cm scale |
| Localization | Most frequently right upper quadrant of the abdomen and/or the epigastrium (representative dermatomes T8/9) |
| Duration | Generally longer than 15-30 min. Can last several hours and be associated non-specific symptoms of indigestion |
| Radiation | Angle of the right scapula and/or shoulder (about 60% of cases), retrosternal area (less than 10% of cases) |
| Associated features | Urgency to walk[162] (two-third of patients), nausea or vomit[42,161,162] |
| Relief | If the stone returns into the gallbladder lumen, passes through the ampulla of Vater into the duodenum or migrates back to the common bile duct[26] |
| First-line therapy | Fast-acting narcotic analgesics (meperidine[163]) or non-steroidal anti-inflammatory drugs (NSAIDs) (im or iv ketorolac or ibuprofen po) which could also reduce the risk of evolution towards acute cholecystitis[164-167] |
| Second-line therapy | Antispasmodic (anticholinergic) agents like hyoscine (scopolamine). Less effective than NSAIDs[164] |
| Recommendations | Fasting, to avoid release of endogenous cholecystokinin and further gallbladder contraction |
Table 3 Indications for “prophylactic” cholecystectomy (i.e., asymptomatic gallstone patients bearing a high risk of becoming symptomatic)
| Children (because they are exposed to the long-term physical presence of stones[58]) |
| Morbid obese patients undergoing bariatric surgery (high risk to become symptomatic during rapid weight loss[62]) |
| Increased risk for gallbladder cancer[63] |
| Patients with large gallstones (greater than 3 cm)[64,65] |
| A “porcelain” gallbladder[66] or gallbladder polyps rapidly growing or larger than 1 cm |
| Native Americans with gallstones (risk of gallbladder cancer 3 to 5 percent)[67] |
| Gallstone patients with sickle cell anemia (formation of calcium bilirubinate gallstones due to chronic hemolysis. Patients may become symptomatic with recurrent episodes of abdominal pain[68]) |
| Coexistence of small gallstones and gallbladder dysmotility (increased risk of pancreatitis[47]) |
Table 4 Major features of the complicated biliary colic
| Additional findings compared to uncomplicated biliary pain | Leukocytosis, nausea, jaundice, vomiting, fever |
| Underlying potential complications | Acute pancreatitis, acute cholecystitis, biliary obstruction and cholangitis, gallbladder perforation, abscess formation, mucocele of the gallbladder |
| Decision | Quick admission to the hospital |
| Therapies | Antibiotics or invasive procedures with or without surgical procedures (Figure 1) |
| Early laparoscopic cholecystectomy recommended between 2 and 4[168] in mild and moderate acute cholecystitis |
- Citation: Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20
- URL: https://www.wjgnet.com/2150-5349/full/v3/i2/7.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i2.7
